Advertisement

ASCO 2020

ASCO: Survival Benefit Emerges in ARAMIS

Darolutamide better in non-metastatic castration-resistant prostate cancer Men diagnosed with non-metastatic castration-resistant prostate cancer live longer if they are treated with darolutamide (Nubeqa) than placebo, the final...

Read More

ASCO: Virtual Meeting Kicks Off May 29

Three days packed with presentations The American Society of Clinical Oncology is the leading oncology research meeting worldwide, but just like other medical conferences, ASCO 2020 was forced to make many changes to deliver on...

Read More

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage